BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29597332)

  • 21. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors.
    Kasheverov IE; Zhmak MN; Vulfius CA; Gorbacheva EV; Mordvintsev DY; Utkin YN; van Elk R; Smit AB; Tsetlin VI
    FEBS J; 2006 Oct; 273(19):4470-81. PubMed ID: 16956365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric modulation of nicotinic acetylcholine receptors.
    Chatzidaki A; Millar NS
    Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of tetrahydropyrroloiminoquinone alkaloids based on electrochemically generated hypervalent iodine oxidative cyclization.
    Inoue K; Ishikawa Y; Nishiyama S
    Org Lett; 2010 Feb; 12(3):436-9. PubMed ID: 20039698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Networking Reveals Two Distinct Chemotypes in Pyrroloiminoquinone-Producing Tsitsikamma favus Sponges.
    Kalinski JJ; Waterworth SC; Noundou XS; Jiwaji M; Parker-Nance S; Krause RWM; McPhail KL; Dorrington RA
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30654589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Perspectives on Pyrroloiminoquinones: Distribution, Biosynthesis and Drug Discovery Potential.
    Kalinski JJ; Polyzois A; Waterworth SC; Siwe Noundou X; Dorrington RA
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substituted 2-Aminopyrimidines Selective for α7-Nicotinic Acetylcholine Receptor Activation and Association with Acetylcholine Binding Proteins.
    Kaczanowska K; Camacho Hernandez GA; Bendiks L; Kohs L; Cornejo-Bravo JM; Harel M; Finn MG; Taylor P
    J Am Chem Soc; 2017 Mar; 139(10):3676-3684. PubMed ID: 28221788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
    Groebe DR; Gray WR; Abramson SN
    Biochemistry; 1997 May; 36(21):6469-74. PubMed ID: 9174364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists.
    Maelicke A; Coban T; Storch A; Schrattenholz A; Pereira EF; Albuquerque EX
    J Recept Signal Transduct Res; 1997; 17(1-3):11-28. PubMed ID: 9029479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allosteric Modulation of Alpha7 Nicotinic Receptors: Mechanistic Insight through Metadynamics and Essential Dynamics.
    Grazioso G; Sgrignani J; Capelli R; Matera C; Dallanoce C; De Amici M; Cavalli A
    J Chem Inf Model; 2015 Dec; 55(12):2528-39. PubMed ID: 26569022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrroloiminoquinone and related metabolites from marine sponges.
    Antunes EM; Copp BR; Davies-Coleman MT; Samaai T
    Nat Prod Rep; 2005 Feb; 22(1):62-72. PubMed ID: 15692617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
    Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
    Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Makaluvamine P, a new cytotoxic pyrroloiminoquinone from Zyzzya cf. fuliginosa.
    Casapullo A; Cutignano A; Bruno I; Bifulco G; Debitus C; Gomez-Paloma L; Riccio R
    J Nat Prod; 2001 Oct; 64(10):1354-6. PubMed ID: 11678667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
    Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
    Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-bromohypaphorine from marine nudibranch mollusk Hermissenda crassicornis is an agonist of human α7 nicotinic acetylcholine receptor.
    Kasheverov IE; Shelukhina IV; Kudryavtsev DS; Makarieva TN; Spirova EN; Guzii AG; Stonik VA; Tsetlin VI
    Mar Drugs; 2015 Mar; 13(3):1255-66. PubMed ID: 25775422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similarities between the Binding Sites of SB-206553 at Serotonin Type 2 and Alpha7 Acetylcholine Nicotinic Receptors: Rationale for Its Polypharmacological Profile.
    Möller-Acuña P; Contreras-Riquelme JS; Rojas-Fuentes C; Nuñez-Vivanco G; Alzate-Morales J; Iturriaga-Vásquez P; Arias HR; Reyes-Parada M
    PLoS One; 2015; 10(8):e0134444. PubMed ID: 26244344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.